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Introduction
Neutrophils (PMNs) possess at least two mechanisms by which they can lyse mammalian target cells. One of these depends upon the production of toxic oxidative metabolites that are generated from the PMNs' respiratory burst (1, 2) . However, a second mechanism, often detected during studies of PMN-induced antibody-dependent cellular cytotoxicity, is independent of the respiratory burst (3) (4) (5) . This latter mechanism is less well understood, but some evidence (6, 7) suggests it is mediated by one or more toxic proteins released from PMN granules.
The most potent cytolytic proteins of PMN granules, at least for leukemia (8) and pulmonary (9) and endothelial (9) targets, are three small (mol wt 3,900) cationic peptides termed defensins or human neutrophil peptides 1, 2, and 3 (HNP [1] [2] [3] .' The human defensins are secreted by activated PMNs (10) and could, therefore, function as cytotoxins during antibody-dependent cellular cytotoxicity. In addition, a synergistic cytotoxic effect occurs when target cells are exposed to a combination of defensins and toxic oxidants (8) . It is, thus, conceivable that defensins may play a role in tissue injury seen during inflammatory or infectious processes.
To investigate the mechanism of defensin-induced injury, we have utilized continuously cultured tumor cells as model targets. In previous studies (11, 12) , K562 cells exposed to defensins began to release radiolabeled chromium after a lag period of 3-4 h. Cytotoxicity depended upon energy metabolism and cytoskeletal activities of the target ( 12) . These results suggested that HNP-mediated lysis was not due to a rapid creation of plasma membrane lesions and that endocytosis of HNP might have to occur before lysis could be realized. However, other evidence indicates defensins rapidly damage biological membranes. They are only active against enveloped viruses (13) ; they create ion channels in model lipid bilayers (14) , and; their lethal effect on Escherichia coli is due to rapid sequential permeabilization of the outer and inner membrane (15) . The results of the present study indicate the initial target structure for defensins on human tumor cells is also the plasma membrane. However, rapid membrane permeabilization, by itself, was insufficient for cell lysis. Ultimate target destruction also depended upon a second phase of injury which required the continued presence of HNP, thus explaining the lag in chromium release. The two phases of injury were independently regulated.
Methods
Tumor targets. The K562, Raji, L929, and YAC-l lines were maintained in vitro by biweekly passage in RPMI media with 10% fetal calf serum (FCS, Reheis, Phoenix, AZ).
Reagents. Human defensins were purified from PMNs to homogeneity as previously described (9) by applying ion exchange and reversephase HPLC followed by gel exclusion chromatography on a long BioGel P-10 column (Bio-Rad Laboratories, Richmond, CA). A mixture ofthe three defensins (HNP 1, 2, and 3 in a ratio of2:2:1 by weight) was used in all experiments except in the binding assay where iodinated purified HNP-1 was used (see below). (2',7')-Bis-carboxy-ethyl)-(5,6)-carboxyfluorescein acetoxymethyl-ester (BCECF-AM) was purchased from Molecular Probes, Eugene, OR. All other reagents were purchased from Sigma Chemical Co., St Counts per minute-maximal was determined by lysis with detergent and control release was determined by incubating cells alone without HNP. Maximal release was always > 90% of incorporated counts and control release remained < 30% ofincorporated counts during the first 35 min ofincubation. Samples were run in quadruplicate and the standard deviation (SD) of replicates was always < 5% of the mean. Chromium release assay. Targets were chromated as previously described (7) and then washed four times. Labeled targets (104 in 0.1 ml ofRPMI) were incubated with or without defensin (in 0.1 ml ofRPMI) in microtiter plates at 370C for varying durations. After incubation, plates were centrifuged, 0.1 ml of supernatant was removed, and counted in a y-counter. Percent specific chromium release was calculated as described above for specific 'Rb release. Maximal (> 90% of incorporated counts) and control values (always < 25% ofincorporated counts) were also determined as for ssRb release. In some experiments (see Tables II and IV) , the chromium release assay was performed in 10 x 75 borosilicate test tubes with 10' chromated targets incubated per tube. The test tubes were centrifuged at 30 or 60 min, HNP-containing media was removed, and targets were resuspended for continuation of the assay. Both cell-free supernatant and pellet were then counted in a y-counter. Simple percent chromium release (in contrast to specific chromium release) was calculated as: cpms,,,icpm,.pa,, + cpmPu,,,) X 100.
Protein synthesis. Protein synthesis was determined as previously described (12) 
Results
Early events of defensin-mediated injury. In previous studies (11, 12) with a chromium release assay, HNP-mediated lysis was first detected by 4 h and increased in linear fashion over the next 14 h. These kinetics suggested lysis was not due to the rapid creation of large plasma membrane pores as can be detected during exposure to perforin (19, 20) . However, defensins can rapidly (within minutes) permeabilize the outer and inner membranes ofE. coli (15) and form anion-selective channels in lipid bilayer model membranes (14) . We, thus, more closely examined the early effects ofHNP on the plasma membrane of K562 cells (Fig. 1 ). Within minutes, defensin significantly decreased the membrane potential of targets, induced the efflux of rubidium from prelabeled cells, and, after a short lag period of 10-15 min, permeabilized the cells for trypan blue (mol wt 960). Collapse of the membrane potential was maintained for at least 30 min (latest time point tested) and specific rubidium release increased linearly over the first 15 min. The internalization of trypan blue increased until -25-30 min, reaching a plateau level where -60% of cells were permeabilized. As we have previously reported (1 1), there was no detectable chromium release from HNP-treated targets until 4 h ofincubation (Fig. 2) . Thus, the early deleterious effects of defensin on the plasma membrane were significant enough to allow transit of small molecules but were insufficient for release of larger chromium-labeled cell components until much later time points.
When targets were incubated with defensin in the presence of 5% FCS, trypan blue internalization was abrogated (Table I) as was collapse of the membrane potential and specific rubid- ium release (not shown). This is probably due to the ability of serum albumin to bind HNP and protect targets (12) . Loss of membrane integrity for trypan blue correlated with the concentration ofHNP used and the temperature ofthe assay (Table I) .
Further evidence of an initial membrane-localized effect of defensin was obtained from continuous recordings ofthe intracellular pH (pHi) of K562 cells (Fig. 3) . The pHi of resting K562 cells was determined to be 6.95. When untreated targets were initially exposed to the potassium-hydrogen exchanger nigericin, a rapid acidification was detected (from pHi 6.94- Comparison of kinetics of chromium release versus trypan blue internalization in HNP-treated targets. K562 cells were incubated with media or HNP (100 yg/ml) for varying durations and percent cytotoxicity in the chromium release assay (.) was compared to "percent cytotoxicity" in the trypan blue exclusion assay (o) and presented as mean±SD of five experiments. In the chromium release assay, percent cytotoxicity = percent specific chromium release (see Methods). In the trypan blue assay, percent cytotoxicity = (1-no.
trypan-negative cells-experiment/no. trypan-negative cells-control) X100. is not sufficient for subsequent cytolysis. To evaluate whether the early HNP-induced adverse effects on plasma membranes was sufficient for cell death detected as chromium release at 6 h, we incubated targets with or without 100 ,ug/ml of HNP for 30 or 60 min, assayed aliquots for trypan blue internalization, and then washed and resuspended the cell mixtures in HNPfree media for continued incubation to a total of 6 h at which time isotope release or trypan blue exclusion was determined (Table II) . In agreement with Figs. 1 and 2, a significant percentage of defensin-treated targets were trypan blue positive relative to untreated controls at the 30-and 60-min time points (Table II, increased cytotoxicity (68±3% specific chromium release at HNP = 100 ,g/ml, i±SD of three experiments) compared to assays run in media alone (50±5% specific release). EGTA did not induce chromium release when used alone (without HNP) and did not presensitize targets to enhanced HNP-mediated lysis when used in preincubation protocols (1 h ofpretreatment followed by washing three times) indicating it did not cause an irreversible nonspecific effect on targets which leads to chromium release. These data suggested calcium protected defensin-treated targets. This was borne out by adding increasing concentrations of exogenous CaCl2 to defensin-target mixtures. Cytotoxicity gradually diminished in a concentrationdependent fashion (Fig. 5) . In contrast, identical concentrations of MgCl2 had no effect on lysis. Chelation of extracellular calcium also greatly accelerated the kinetics of HNP-mediated lysis. EGTA (5 mM) allowed significant cytolysis of defensin-treated targets as early as 60 min of incubation in contrast to the 4-6 h required for exposure to defensin alone (Fig. 6 ). These results further support the finding that a potentially lethal event is induced by HNP as early as 60 min after incubation. The binding ofradiolabeled defensin to K562 targets over a 1-h incubation was 58±5% of counts per minute bound (mean±SD of three experiments). The addition of cycloheximide (53±4% bound), actinomycin D (51±7%), 5 mM EGTA (57±4%), or 1.4 mM exogenous CaCl2 (60±4%) did not significantly affect binding.
Modulation ofthe initialphase ofHNP injury. As shown in Fig. 1 and Table II , the first phase of HNP-mediated injury plateaued by 30 min of incubation and the second phase was initiated between 30 and 60 min. The absence of overlap between the two phases allowed us to investigate their independent regulation. Fig. 7 demonstrates that the combination of azide and 2-deoxyglucose as well as cytochalasin B were capable ofprotecting against defensin-induced loss of membrane integrity. In contrast, actinomycin D, cycloheximide, EGTA, and excess CaCl2 had no effect. The drugs were used in concentrations that were not toxic, by themselves, to targets. It should also be noted that, in these experiments, targets were first exposed to drugs alone for 20 min and defensin was then added for 10, 20, 30, or 60 min more. It is certainly possible that the development of permeabilization would be sensitive to some reagents iflonger incubations with the drugs were used. We utilized this protocol since the effects on defensin-mediated chromium release at 6 h also was determined by exposing cells to drugs for 20 min before addition of defensin. Modulation ofthesecondphase ofdefensin injury. To investigate the second phase of HNP-mediated injury, chromated targets were incubated with defensin or media (control) for 60 min, at which time HNP-containing media was washed away and targets were resuspended in media or various agents for continuation of the chromium release assay. Released isotope was assayed 5 h later (6-h chromium release assay). When targets were treated with defensin for 60 min followed by washing and resuspending in defensin-free media, significantly in- creased chromium release over nontreated controls was evident at 6 h (group A, Table IV) , which is consistent with the data presented in Table II . However, when HNP-treated cells were resuspended at 1 h in azide/2-deoxyglucose or excess CaCl2 (groups B and E), cytotoxicity was prevented. Azide/2-deoxyglucose and excess calcium, thus, protect against the second phase ofdefensin-injury. IfHNP-treated targets were resuspended at 1 h in cytochalasin B, resulting cytotoxicity at 6 h was unaltered (group C). However, resuspension at 1 h in EGTA, actinomycin D, or cycloheximide (groups D, F, and G) significantly enhanced cytolysis of defensin-treated targets while having little effect on control K562 cells incubated in media alone during the first hour. Thus, these latter reagents enhance the second phase of defensin-mediated injury. Mechanism of resistance to defensin in L929 targets. We previously documented that murine L929 targets were quite resistant to the cytotoxic action of HNP when tested by chromium release at 6 h (12). Table V demonstrates that they are also resistant to early membrane permeabilization for trypan blue. In contrast, binding of radiolabeled defensin to L929 targets is comparable to sensitive YAC-l and K562 cells.
Discussion
The results of this study indicate that, after binding of HNP to the target cell plasmalemma, small membrane channels that permit ion flux are rapidly created. Although we have not ruled out the possibility that the depressed acidification response to nigericin is due to an HNP-induced stimulation ofcellular metabolism and a resulting increased acid load, the rapid collapse of the membrane potential and early leak of rubidium make it more likely-that defensin induced proton influx and potassium efflux to account for those results. Moreover, these rapid changes were soon followed by permeabilization for trypan blue, further supporting the initial breach of membrane integrity. However, the breach is insufficient, by itself, for subse- (12) where we found that cytochalasin-sensitive events were complete by 1 h of incubation with HNP but azide/2-deoxyglucose continued to be inhibitory to lysis when added as late as 2 h after defensin. Although membrane permeabilization is identical to membrane binding of HNP in its temperature, concentration, and serum dependence (12) , they differ in that binding is independent of energy metabolism and cytoskeletal function (12) . In addition, although resistant L929 cells were not permeabilized, their binding of I-HNP is comparable to that ofsensitive targets (Table V) . These data indicate binding can be dissociated from membrane permeabilization. On the other hand, the characteristics ofpermeabilization correlate closely with those ofcytolysis at 6 h suggesting the initial membrane-active events are critical for lysis. The lack of HNP-induced permeabilization of L929 cells also correlates with the significant resistance ofthese targets to lysis, providing further support for the importance of the initial membrane injury. The absence of permeabilization in L929 cells may be due to a different biochemical structure of L929 cell membranes. Alternatively, since permeabilization is also determined by target-dependent processes, L929 metabolism may be singularly insufficient for generating membrane pores.
The initial permeabilization phase of injury was antagonized by interferring with target cell energy metabolism. Similar results were obtained when E. coli were exposed to HNP (15) as mitochondrial poisons prevented outer and inner membrane permeabilization. Defensin-induced ion channels in model lipid bilayer membranes are strictly voltage dependent (14) . Defensin injury to the plasmalemma may, thus, be specific for an "energized membrane," providing one possible explanation for the energy dependence. The data presented in Fig. 4 also supports this hypothesis since increasing the extracellular potassium concentration, which would decrease the membrane potential, protected targets from defensin. However, an alternative explanation for the results of Fig. 4 is that potassium efflux is involved in the HNP-mediated permeabilization for trypan blue.
The voltage-dependent channels induced in model membranes by human and rabbit defensins rapidly close when the voltage across the membrane is reversed (14) . If HNP-induced channels created in tumor cell membranes are similarly voltage-dependent, one might expect channel closure when the membrane potential initially collapses in the first 5-10 min. It is unclear how channels would then remain open to allow subsequent internalization of trypan blue. One possibility is that the target's cytoskeleton interacts with HNP to stabilize it in the membrane and ultimately render its channel voltage insensitive. This would explain the inhibition of defensin-mediated trypan blue permeabilization mediated by cytochalasin B. Alternatively, the defensin-induced membrane channels may become voltage insensitive over time without a requirement for an active participation by the target cell. In fact, although current can be completely turned offby reversing the voltage at early times after addition ofHNP to model membranes, a voltage-independent current gradually develops (14) .
An alternate explanation for the inhibition ofpermeabilization by cytochalasin B is that cytoskeletal processes may serve to enlarge the initial pore such that substances of at least 960 mol wt (that oftrypan blue) can gain access to the target. Since cytochalasin B also protects targets against lysis, this hypothesis implies that the size of the membrane pore is critical for determining the ultimate fate of the target. A threshold pore size would determine if and when critical cellular metabolites are lost or whether defensin molecules (mol wt 3,900) could easily gain entry to the interior of the target where a subsequent "lethal hit" may take place. After permeabilization, subsequent lysis depends upon the continued presence of defensin molecules, supporting this latter notion. The inhibition of the second phase of injury with azide/2-deoxyglucose also suggests that an active lethal hit occurs after permeabilization rather than a simple loss of metabolites. When K562 targets were resuspended in fresh media after a 30-min incubation in HNP, a time at which at least 50% were trypan-blue-stained, efficient repair of membrane damage occurred. Since actinomycin D and cycloheximide enhance HNP-mediated lysis through their effects on the second phase ofinjury, it is possible that de novo protein synthesis is required for membrane repair. Alternatively, protein synthesis may protect targets against defensin by other mechanisms.
The effects of altered calcium concentration on HNP-induced injury may also be due to modulation of membrane repair. Chelation ofcalcium enhanced and the addition ofexogenous calcium (but not magnesium) depressed HNP-mediated chromium release. These alterations in calcium concentration did not affect the initial permeabilization but effectively modulated the second phase ofinjury. In similar fashion, the absence of calcium markedly enhances the lysis of mammalian cells exposed to the membrane pore-forming proteins staphylococcal-alpha toxin (21) and the terminal attack complex of complement (22) . The increased sensitivity of cells to lysis in the absence of calcium may be due to an impaired repair mechanism (21, 22) . For example, when the number of C5b-9 complexes generated on nucleated targets is limited, membrane channels can form that permit ion flux but do not result in subsequent cytolysis (23) . Targets are capable of repairing limited numbers of pores by endocytosis of the transmembrane channels (23) and endocytosis is triggered by the influx of calcium (22) . In the absence of calcium, the channels will persist and targets will be more likely to die. Protection of targets by subphysiological concentrations of calcium (as well as by serum proteins [11, 12] ) suggest that HNP-mediated cytolysis of tumor cells might not occur in vivo.
The adverse effects of defensins on microbes is somewhat similar to the effects on tumor cells. First, HNP sequentially permeabilizes the outer and inner membranes ofE. coli which is critical for bacterial death (15) . Secondly, E. coli (15) and Candida albicans (24) are susceptible to defensins only when they are actively undergoing energy metabolism and mitochondrial poisons prevent outer and inner membrane permeabilization ofE. coli (15) . These results are similar to the protection seen when tumor cells are exposed to defensins in the presence of azide combined with 2-deoxyglucose. Third, divalent cations appear to protect against the microbicidal as well as cytocidal effects of defensins.
However, there are also differences between the activity of defensins on microbial versus tumor cell targets. Outer and inner membrane permeabilization was sufficient for the bactericidal effects (15) whereas an event subsequent to permeabiliza-tion was required for tumor cell lysis. This may be due to a greater capacity of mammalian cells to repair membrane damage. Also, while both calcium and magnesium cations protect against candidacidal effects ofHNP-1 (24), only excess calcium protects against lysis of tumor cells. Finally, excess calcium protects against outer and inner membrane permeabilization of E. coli (15) while it had no effect on the permeabilization of K562 membranes. Thus, the data suggest similarities in the initial interaction between HNP and outer membranes of microbes and tumor cells. However, the regulation ofthese events and the subsequent phases of injury differ.
The membrane-permeabilization characteristics of defensins are similar to other channel-forming proteins. Common to these peptides is the ability to form an amphiphilic complex although they may achieve this by different means. The bee toxin mellitin (25) and the antibacterial magainin peptides (26) are capable of forming alpha helices of an amphiphilic nature. In contrast, complement (27) and staphylococcal alpha toxin (28) are hydrophilic polypeptides that self-associate on target cells to form membrane-penetrating amphiphilic complexes. The amphiphilic topology of the nonhelical defensins appears to be conferred by alternating sequences of hydrophilic and hydrophobic amino acid residues (29) . Defensin molecules may also self-associate on target membranes although we have no direct evidence for this. Ifso, such polymerization would be calcium and magnesium independent.
